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A B S T R A C T
The aim of the study was to determine the frequency of fetal macrosomia in newborns from mothers with gestational
diabetes mellitus (GDM) and healthy mothers, as well as determining the influence of fetal growth on pregnancy termi-
nation, on complications in pregnancy, during delivery and puerperium and on neonatal complications. In the study
were included 351 pregnant women with GDM, as well as control group of 1502 healthy pregnant women. Newborns of
mothers with GDM had significantly higher birth weight and length, ponderal index >2.85 was more frequent, they
were macrosomic and hypertrophic (disproportional and proportional), had smaller Apgar score and more frequent neo-
natal complications (p<0.05). Fetal macrosomia and fetal hypertrophy alone or, particularly, connected with dispropor-
tional fetal growth, but disproportional hypotrophy as well, had significantly influence on greater frequency of delivery
and puerperal complications, delivery completion with Cesarean section and neonatal complications in pregnant women
with GDM.
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Introduction
Gestational diabetes mellitus (GDM) is a carbohy-
drate intolerance that is manifested by hyperglycaemia.
GDM is caused by insulin resistance and is firstly noted
during pregnancy, wherein it shows adverse effects on
the pregnancy itself, on the fetus and on future life of
both the mother and the offspring. An incidence of GDM
is 2–14%, which depends on population and ethnic fac-
tors, and also on different diagnostic parameters used1,2.
Although the exact mechanism of insulin resistance
during pregnancy is not known, its known causes in-
clude: decrease of insulin receptors in target tissues,
postreceptor blockage, an antireceptor activity of poly-
clonal antibodies, defects in the cellular mechanism of
immune tolerance, defects of different genes, and finally
the effects of hormone changes on homeostasis of glucose
and lipids3,4.
Fetal growth is a complex process that involves inter-
actions among mother, placenta and fetus. Newborn’s
birth weight is the result of genetic predisposition, avail-
able substrates (quantity of glucose, lipids, amino acids),
and mother’s and fetal endocrine statuses, all of which
also determine a postnatal growth rate5.
The most important source of energy for a fetus is
glucose, whereas insulin and insulin like growth factor I
(IGF-I) are the most important growth hormones, which
positively correlate to his growth6,7. Fetal macrosomy can
be defined as a body weight above 4000 grams at term
and large-for-gestational age baby above the 90th per-
centiles for a reliable gestational age or when it’s weight
is two standard deviations above the median of weight
birth defined for defined population8–10. Chronic hyper-
insulinemia in fetuses from diabetic pregnancies leads to
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increase in total body mass with a moderate increase in
body length accompanied with selective organomegalia,
which is a result of hypertrophy of insulin-sensitive tis-
sues. Newborn is not only large, but it has a dispropor-
tionately big trunk, wide shoulders in relation to the
head measurements (there is lower ratio of head circum-
ference in relation to shoulder width), a larger extremi-
ties diameter, higher values of skin folds and higher pro-
portion of fat in the total weight11. Fetal growth is one of
the criteria for determining clinical methods of treat-
ment of pregnant women with diabetes12.
Significant problems in pregnant women with GDM
are complications in pregnancy (urogenital infections,
hypertension and pre-eclampsia) that correlate with poor
metabolical control and perinatal outcome11,13. Pregnan-
cy with GDM is characterized by an increase in the fre-
quency of congenital malformation, neonatal complica-
tions (hypoglycemia, cardio-respiratory disorders, respi-
ratory distress syndrome, anomalies, hyperbilirubinemia,
macrosomy associated with injuries during delivery), as
well as obesity and diabetes in childhood and later10,14.
Frequency of neonatal complications is higher in the
group of disproportional asymmetrical metabolic macro-
somy in relation to proportional symmetric constitu-
tional macrosomy15.
Due to the frequent complications in pregnant women
with GDM, delivery should be completed earlier, and the
rate of the Caesarean section in recent years reaches
60%11,16.
The aim of the study was to determine the frequency
of macrosomal fetal growth in newborns from healthy
mothers and mothers with GDM, as well as determining
the influence of fetal growth on pregnancy termination
and on the frequency of complications in pregnancy, dur-
ing delivery and puerperium and on neonatal complica-
tions. This paper describes the increased frequency of fe-
tal macrosomy, especially the disproportionate macro-
somy, as well as higher frequency of deliveries completed
by Caesarean section, more frequent complications dur-
ing pregnancy, delivery and newborn’s period in preg-
nant women with GDM compared to healthy pregnant
women. This study differs from earlier reports by its use
of ponderal index (PI) in relation to percentile curve.
Materials and Methods
This prospective study was made on patients from the
Division of Diabetes and Fetal Growth of the Depart-
ment of Gynecology and Obstetrics, University Hospital
Center Zagreb, in the period 1995–2003. In the study,
351 pregnant women with GDM were monitored, as well
as control group of randomly selected 1502 healthy preg-
nant women with singleton pregnancy of same gesta-
tional age, newborn’s gender and similar mothers’ parity.
All pregnancies ended between gestation weeks 28th
and 44th by delivery of a live newborn. Gestational age
was determined by the duration of amenorrhea, that was
confirmed by the ultrasonic biometry during pregnancy;
after delivery the gestational age was estimated by using
the method of Farr. Diagnosis of GDM is set according to
the criteria of the World Health Organization17. Individ-
ual data on age and parity, complications in pregnancy,
delivery and puerperium, mode of delivery and neonatal
complications in pregnant women with GDM, as well as
in the control group were analyzed.
Group of pregnant women with GDM consisted of 278
pregnant women with good regulation of glycaemia dur-
ing pregnancy achieved only through diet with up to
1800 kcal per day. Other 73 pregnant women with GDM
were on the same diet but, due to the elevated glycaemia,
they were on insulin therapy, too.
Gestational age, birth weight (BW), length at delivery
(BL), ponderal index (PI=BW g/BL3 cm×100) together
with percentile values (CV), Apgar score at the end of
first and fifth minute, blood pH values from umbilical
cord and neonatal complications in newborns were ana-
lyzed.
The frequency of macrosomy and disproportional ma-
crosomy in newborns were determined and its coherence
with the way of completion of pregnancy and complica-
tions was analyzed. Ponderal index values lover than
2.32 and ponderal index higher than 2.85 were indicative
for disproportional growth of newborns. Infants were
classified, according to percentile values and corrected
percentile values for the newborns weight of defined
weeks of pregnancy by mother’s parity and child’s gen-
der coherent to the year 1982 in Zagreb18 into three
groups: hypotrophic (<10 percentiles), eutrophic (10–90
percentiles) and hypertrophic (>90 percentiles).
To test the difference between the studied groups
univariant analysis of variance (ANOVA) was performed,
while to test quantitative variables student T-test for in-
dependent samples were implemented. The difference be-
tween the studied groups for qualitative data was tested by
÷2-test for independent samples as well as by Fisher’s
test. P value <0.05 was considered as statistically signifi-
cant. Statistical analysis was performed using SPSS soft-
ware package (SPSS for Windows 11.5, SPSS Inc., Chi-
cago, IL, USA).
Results
All pregnant women (both healthy and those with
GDM) analyzed in this study were of the same gesta-
tional age (39.63±1.98 vs. 39.33±2.14 weeks, F=1.567,
p=0.211), of the same newborn’s gender (c2=0.015, p=
0.906), and had the same parity (c2=0.468, p=0.513).
The women with GDM were significantly older than
the healthy ones (31.56±5.73 vs. 28.19±5.19 years, F=
9.735, p=0.002), and thus more often 30 years old
(217–62.8% vs. 574–38.2%, c2=63.346, p=0.0001). How-
ever, a relatively high frequency of GDM was noted in
pregnant women of less than 30 years old (38.2%), and
also in those younger than 25 (11.1%).
The GDM group, in previous pregnancies, had an in-
creased rate of spontaneous abortions (90–25.6% vs. 235–
15.6%, c2=19.653, p=0.0001), with more frequent intra-
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uterine and subpartal deaths (17–4.8% vs. 23–1.5%, c2=
14.777, p=0.0001), and also neonatal deaths (15–4.3% vs.
18–1.2%, c2=15.381, p=0.0001).
The average hospitalization period of pregnant wo-
men with GDM was significantly longer compared to the
healthy ones (2.49±1.54 vs. 0.22±0.57 days, F=2074.396,
p=0.0001), due to increased incidence of complications
(p<0.05): polyhydramnion, Rh immunization, cerclage
cervicis, hypertension, urinary infections, congenital
malformations. Hypertension was several fold more fre-
quent in women with GDM than in healthy ones (34–
9.7% vs. 21–1.4%, c2=67.866, p=0.0001), as well as pre-
-eclampsia (27–7.7% vs. 40–2.7%, c2=20.649, p=0.0001),
chronic hypertension (14–4.0% vs. 18–1.2%, c2=13.036,
p=0.0003), and asymptomatic bacteriuria (47–13.4% vs.
93–6.2%, c2=21.109, p=0.0001). The frequency of pre-
mature deliveries was increased in pregnant women
with GDM (11.4%) too, in relation to the control group
(9.2%).
The frequency of prepathological (23–6.6% vs. 55–
3.7%, c2=5.602, p=0.018) and pathological (13–3.7% vs.
19–1.3 %, c2=9.679, p=0.002) cardiotocograms was sig-
nificantly higher in pregnant women with GDM, as com-
pared to the healthy ones. They also had increased rate
of delivery and puerperal complications (28–8.0% vs.
32–2.1%, c2=31.042, p=0.0001).
The average weight and length of newborn babies
from mothers with GDM was significantly higher than of
those from healthy mothers (p<0.05), except the pon-
deral index for which the difference was not significant
(Table 1).
Newborns are divided into three groups based on
ponderal index: disproportional small (<2.32), propor-
tional (2.32–2.85), and disproportional large (>2.85).
The newborns of mothers with GDM were significantly
more disproportional large than those of healthy moth-
ers, which were dominantly of proportional size (Table
2).
Table 3 presents the frequency of macrosomic new-
borns that weighted 4000 grams and 4500 grams, and
also the rate of ponderal index dependant macrosomic
proportional and disproportional growth. Significantly
higher incidence of macrosomic growth was observed in
the group of newborns from mothers with GDM (p<
0.05). As with macrosomic newborns, the frequency of
hypertrophic newborns (CV>90) was much higher in the
group of mothers with GDM, than in the control group
(120–34.2% vs. 230–15.3%, c2=66.161, p=0.0001).
The viability of newborns was estimated by an Apgar
score, determined at the end of the first and fifth minute
after birth. The average Apgar score values were signifi-
cantly lower in neonates from mothers with GDM both
in the first (9.37±1.37 vs. 9.71±1.02, F=28.221, p=0.0001),
and in the second (9.74±0.70 vs. 9.90±0.58, F=19.767,
p=0.0001) measurement. The frequency of neonates with
Apgar score 4–7, according to the first measurement, was
considerably higher in a group of mothers with GDM
(28–8.0% vs. 56–3.7%, c2=11.868, p=0.001). There were
no statistical differences of the rate of Apgar score below
7 (6–1.7% vs. 20–1.3%) and Apgar score below 4 (0–0.0% vs.
3–0.2%) at the fifth minute among both groups (p>0.05).
Newborns from mothers with GDM showed an in-
creased rate of both congenital malformations (18–5.1%
vs. 29–1.9%, c2=11.766, p=0.001) and neonatal compli-
cations (133–37.9% vs. 300–20.0%, c2=51.012, p=0.0001):
hyperbilirubinemia, perinatal infections, kefalhaematho-
ma, clavicular fracture, brachial plexus injuries. During
early neonatal period two newborns died in a group of
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TABLE 1
THE MEAN VALUE OF BIRTH WEIGHT, BIRTH LENGTH AND PONDERAL INDEX OF NEWBORNS FROM WOMEN WITH






Birth weight (g) 3506.6±732.7 3350.2±585.1 18.372 0.0001
Birth length (cm) 50.4±3.1 49.9±2.7 9.884 0.002
Ponderal index 2.69±0.27 2.67±0.24 3.300 0.069
GDM – gestational diabetes
TABLE 2
PONDERAL INDEX OF NEWBORNS FROM MOTHERS WITH GESTATIONAL DIABETES AND HEALTHY ONES




<2.32 21 (6.0) 97 (6.5) 0.108 0.743
2.32–2.85 234 (66.6) 1086 (72.3) 4.412 0.036
>2.85 96 (27.4) 319 (21.2) 6.115 0.013
GDM – gestational diabetes
mothers with GDM, while in the other group died four
(0.6% vs. 0.7%, c2=0.812, p=0.368). These differences
are not statistically relevant.
The mothers with GDM had increased frequency of
Caesarean section (132–37.6% vs. 134–8.9%, c2=190.421,
p=0.022). No difference was observed concerning fetal
presentation nor did it influenced the delivery methods
(p>0.05).
In mothers with GDM that delivered their newborns
by Caesarean section, it was correlated with macrosomic,
disproportional macrosomic and disproportional hyper-
trophic newborns (p<0.05). The greatest frequency of
Caesarean section occurred in mothers with GDM that
carried disproportional hypotrophic newborns (90.0%),
while it was lower in cases where newborns were eutro-
phic (32.8%), or proportional eutrophic (30.1%), or pro-
portional hypotrophic (17.6%). Healthy mothers deliv-
ered hypertrophic and hypotrophic newborns (11.7%) by
Caesarean section mostly than eutrophic (8.0%) (Table
4).
No difference was noted among mothers with GDM
concerning frequency of delivery and puerperal compli-
cations in relation to the size of a neonate, while in the
group of healthy mothers much more complications oc-
curred when disproportional hypertrophic (5–4.9% vs.
26–1.9%, c2=4.260, p=0.039) and disproportional eutro-
phic (5–9.6% vs. 26–1.8%, c2=15.196, p=0.0001) new-
borns were delivered.
As neonatal complications are concerned, children de-
livered by mothers with GDM had the most frequent
complications when macrosomic proportional (³4000 g,
PI 2.32–2.85) (20–54.1% vs. 121–36.9%, c2=4.591, p=
0.032), macrosomic proportional (³4500 g, PI 2.32–2.85)
(5–83.3% vs. 128–37.1%, c2=5.356, p=0.021), hypertro-
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TABLE 4
IMPACT OF FETAL GROWTH ON THE COMPLETION OF DELIVERY
Fetal growth (n=GDM/Healthy)
Caesarean section – n (%)
GDM (n=132) Healthy (n=134) p
Macrosomic ³4000 g (84/185) 33 (39.3) 16 (8.6) 0.0001
Macrosomic ³4500 g (23/29) 14 (60.9) 3 (10.3) 0.0002
Proportional macrosomic (37/90) 9 (24.3) 4 (4.4) 0.002
Disproportional macrosomic (47/95) 24 (51.1) 12 (12.6) 0.0001
Hypotrophic (27/137) 2 (11.8) 24 (17.5) 0.739
Eutrophic (204/1135) 66 (32.4) 91 (8.0) 0.0001
Hypertrophic (120/230) 54 (45.0) 19 (8.3) 0.0001
Disproportional hypertrophic (60/103) 32 (53.3) 12 (11.7) 0.0001
Proportional hypertrophic (60/127) 21 (35.0) 7 (5.5) 0.0001
Disproportional large eutrophic (36/220) 16 (44.4) 13 (5.9) 0.0001
Proportional eutrophic (156/863) 47 (30.1) 69 (8.0) 0.0001
Disproportional small eutrophic (12/52) 4 (33.3) 9 (17.3) 0.243
Proportional hypotrophic (17/87) 3 (17.6) 8 (9.0) 0.378
Disproportional hypotrophic (10/48) 9 (90.0) 16 (33.3) 0.001
GDM – gestational diabetes
TABLE 3
FREQUENCY OF MACROSOMIC NEWBORNS FROM MOTHERS WITH GESTATIONAL DIABETES AND HEALTHY ONES




<4000 267 (76.0) 1317 (87.7) 30.929 0.0001
4000 84 (24.0) 185 (12.3) 31.797 0.0001
4500 23 (6.6) 29 (1.9) 22.284 0.0001
4000 proportional 37 (10.5) 90 (6.0) 9.224 0.002
4000 disproportional 47 (13.5) 95 (6.3) 20.436 0.0001
4500 proportional 6 (1.7) 9 (0.6) 4.367 0.037
4500 disproportional 17 (4.8) 20 (1.3) 17.930 0.0001
GDM – gestational diabetes
phic (55–45.8% vs. 78–32.4%, c2=4.887, p=0.027), and
less so if they were eutrophic (67–32.8% vs. 66–44.9%,
c2=5.276, p=0.022) and eutrophic disproportional (PI
>2.85) (8–22.2% vs. 125–39.7%, c2=4.185, p=0.041). On
the other hand, in the group of healthy mothers the inci-
dence of neonatal complications was much higher in dis-
proportional hypotrophic (PI <2.32) (17–35.4% vs. 283–
19.5%, c2=7.395, p=0.007), and disproportional eutro-
phic (PI <2.32) (19–36.5% vs. 281–19.4%, c2=9.247, p=
0.002) newborns.
Discussion
This study has presented the increased frequency of
fetal macrosomy, especially the disproportional macro-
somy, higher frequency of deliveries completed by Cae-
sarean section, complications in pregnancy, during deliv-
ery, puerperium and neonatal complications in pregnant
women with GDM compared to the healthy pregnant
women.
Maternal age and increase of the age is considered to
be the highest relative risk for the emergence of GDM.
The risk increases after the age of 2519. The results of
this research confirm the influence of age on the fre-
quency of GDM, as well as the legitimacy of the screening
on GDM in the age groups younger than 30 years.
Increased frequency of hypertension in pregnancy
and preeclampsia among pregnant women with GDM
can be associated with poor metabolic control of the dis-
ease and with the mother’s constitutional factor of in-
creased sensitivity of endothelial activity, while poor pla-
centation plays a minor role20. Cartagena21 has establi-
shed less perinatal complications in pregnant women
with GDM who had better perinatal care. Significantly
higher frequency of pre-term birth in pregnant women
with GDM in comparison with the control group was not
found. Similar results were found by Yogev and Langer
in 1526 pregnant women with GDM with the frequency
of pre-term birth of 10.7%, which was not different from
the control group of healthy pregnant women. Better
metabolic control of glycaemia reduced the frequency of
premature delivery22. Significantly higher frequency in
prepathologic and pathologic cardiotocogram records in
pregnant women with GDM refers to chronic hypoxia in
fetuses of mothers with GDM23.
Djelmi{ et al. in the earlier works found significantly
higher birth weight values (3558.2±817.6 g vs. 3132.4±
534.4 g), ponderal index (2.82±0.28 vs. 2.63±0.24), ma-
crosomy (53.4% vs. 8.3%) and disproportional macro-
somy (35.2% vs. 5.8%) in pregnant women with diabetes
compared to healthy ones24. Results of this survey are in
accordance with their results. This work shows in detail
the prevalence of macrosomal newborns (PT 4000 g and
PT 4500 g), as well as the frequency of the same
macrosomy groups (that with proportional and dispro-
portional growth specified by ponderal index and percen-
tile values). Frequency of all subgroups of macrosomal
newborns in women with GDM, disproportional macro-
somy as well as proportional and disproportional hyper-
trophic newborns, was statistically significantly higher
compared to the control group. Authors from Slavonski
Brod have found an increased frequency of GDM from
1.0 to 6.7%, decrease of frequency of macrosomy from
13.3 to 12.2% and decreased frequency of perinatal mor-
tality, preterm birth, fetal and maternal complications in
pregnancy and on child birth, as a result of an appropri-
ate estimation of glucose tolerance during pregnancy25.
Authors from Bosnia and Herzegovina have found that
the frequency of macrosomy (4000 g) in 13.1% of preg-
nant women was associated with the prolonged preg-
nancy, mother’s obesity, GDM, hypertension and male
gender of the newborns, as well as bad perinatal out-
come26. Diabetic pregnancy is associated with higher fre-
quency of macrosomy, accelerated and larger fetal gro-
wth that are matched with a higher frequency of dispro-
portional growth.
Mother’s hyperglycaemia leads to fetal hyperglycae-
mia and hyperinsulinemia, which causes hyperplasia and
hypertrophy of the Langerhans’ islets and, consequently,
increased growth of fetal tissues and organs. Whereas
placenta does not allow transfer of fetal insulin to mo-
ther, a large quantity of mother’s glucose is metabolized
in the fetus leading to increased lipogenesis, viscero-
megalia and excessive growth of the fetus. Research has
proven that macrosomal newborns from mothers with di-
abetes have a significantly higher level of insulin in um-
bilical vein than eutrophic and hypotrophic newborns,
that confirms the importance of insulin as the most im-
portant tissue growth hormone. Positive correlation be-
tween glucose and insulin in the fetal circulation and
amniotic fluid shows their strong influence on fetal gro-
wth. Significantly higher were the value of IGF-I from
umbilical vein’s blood, and they were in positive correla-
tion with fetal growth and duration of pregnancy, while
the value of growth hormone were lower in comparison
to eutrophic and hypotrophic newborns7.
Due to the chronic intrauterine hypoxia, fetuses of
pregnant women with GDM have lower Apgar score and
lower umbilical vein pH in comparison to the control
group23. A low Apgar score at first minute is often caused
by a temporary depression, whereas low fifth-minute
score usually is associated with several obstetric risk fac-
tors and implies complications of clinical importance27.
Congenital malformations and neonatal complicati-
ons were significantly more often in the group of preg-
nant women with GDM in comparison to the control
group, while significant differences in early neonatal
mortality rate among the investigated groups were not
present.
This work shows significantly higher frequency of
completion of birth through Caesarean section, as well as
a significant influence of fetal macrosomy and fetal hy-
pertrophy alone, especially when associated with dispro-
portional fetal growth, as well as a significant influence
of disproportional eutrophy and hypotrophy on the in-
creased frequency of birth completion by Caesarean sec-
tion in pregnant women with GDM compared to healthy
pregnant women. Navti et al.28 found fetal macrosomy
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(4500 g) in 1.4% of pregnant patients, where 61.6% of
the deliveries began spontaneously, they were induced in
31.6%, while in 6.8% elective Caesarean section was per-
formed. The delivery was in 65.8% completed spontane-
ously vaginal, in 17.5% operative vaginal and in 16.7% by
emergency Caesarean section. Frequency of shoulder
distocia and of Caesarean section was significantly hig-
her. Macrosomy in newborns is the indirect cause of in-
creased frequency of Caesarean section in women with
borderline and untreated GDM. Despite the regulation of
GDM and normalization of birth weight, the frequency of
births completed by Caesarean section remains high29.
Miller and Gillmer believe that diabetes in pregnant
women is not indication for Caesarean section. If the es-
timation of fetal weight is exceeding 4250 grams or if
there is a significant difference in the proportion of the
value of the circumference of the abdomen and head of
the fetus, elective Caesarean section should be consid-
ered. Completion of the delivery by Caesarean section is
neither routine indication, nor contraindication. Increa-
sed incidence of fetal macrosomy and risk of injury during
delivery, due to cephalopelvic disproportion and shoulder
dystocia, call for an evaluation of fetal weight before
completion of the delivery by vacuum extraction or for-
ceps16. Many studies emphasize the completion of preg-
nancy with fetal macrosomy by Caesarean section, while
others do not confirm that30. Active, rather than expec-
tant management of labor at term for women with GDM,
may reduce rates of macrosomia and related compli-
cations31. Women diagnosed with GDM by the Carpenter
and Coustan criteria, but not by the National Diabetes
Data Group criteria, had higher risk of operative deliver-
ies, macrosomia and shoulder dystocia32.
This investigation presented a significantly higher
frequency of neonatal complications in proportional and
hypertrophic macrosomic newborns from pregnant wo-
men with GDM. In the group of healthy pregnant women
significantly higher frequency of neonatal complications
was observed in hypotrophic and eutrotrophic dispropor-
tionate newborns. Ballard et al.15 found 45% macrosomal
and 19% of disproportionate macrosomic newborns in
mothers with GDM, as compared to 8% and 1%, respec-
tively, in the control group, indicating a significantly
higher frequency of complications in neonatal dispropor-
tionate macrosomic newborns from mothers with GDM.
Boulet et al.33 found an increased risk of delivery as well
as neonatal complications involving macrosomic chil-
dren. Number of complications increases with the weight
above 4500 grams; the infant’s weight over 5000 grams
was a significant indicator of risk for unfavorable neona-
tal outcome. A frequency of fetal death increases with
the fetal weight 4250 grams in nondiabetic pregnancies
and 4000 grams in diabetic ones34. Anoon et al.35 found
0.24% of newborns with delivery weight 5000 grams
(68% of male newborns among them), with their mothers
being significantly older, excessively heavy weighted, mul-
tiparas, with GDM, with prolongated pregnancy, or hav-
ing earlier macrosomic children. These deliveries were
accompanied with a significantly greater frequency of
Caesarean section, postpartal haemorrhage, fetal hypo-
xia, shoulder injury and neonatal traumas after vaginal
delivery, which occurred with a frequency of 59.5%. In
that study fetal macrosomy and fetal hypertrophy alone
or combined with disproportionate fetal growth had the
strongest impact on the increased frequency of neonatal
complications among pregnant women with GDM.
Intrauterine changes of the fetus in pregnant women
with diabetes in later life have long-term consequences
for the regulation of glucose homeostasis and insulin sen-
sitivity. Consequence of early damage of the development
of pancreatic b-cells is occurrence of impaired glucose or
diabetes in adult age36. Women with GDM in early preg-
nancy have a high risk of developing diabetes (especially
diabetes mellitus type 2) in later life. They show charac-
teristics of insulin resistance, such as the central type of
obesity, dislipidemia and hypertension associated with
increased morbidity as well as significantly higher fre-
quency of glucose intolerance and metabolic syndrome.
Young women with GDM are the group with high risk,
but by changing the way of life possible cardiovascular
complications and progression to diabetes would be redu-
ced37.
The main problems of diabetic pregnancies are con-
genital anomalies, spontaneous miscarriages, misregu-
lation of fetal growth, occurrence of hypertension, fetal
hypoxia, also the methods of birth completion, and neo-
natal complications.
Conclusion
As a conclusion, an optimal regulation of glycaemia
(by diet or insulin) in pregnant women is of fundamental
importance for the prevention of diabetic complications
during pregnancy. There is a need for good preconception
metabolic regulation of the disease, also a self-control
during pregnancy, ultrasonic monitoring of the fetus,
good cooperation of obstetricians and diabetologists and,
finally, the care of diabetic pregnancy in a regional cen-
ter. An elimination of congenital anomalies, the reducing
of complications of pregnancy and birth, a lower of fre-
quency macrosomy and neonatal complications, even
very low perinatal mortality, similar to the one in the
general population, would be achieved by an early detection
and treatment of hypertension and bacteriuria, along
with fetal monitoring at the end of pregnancy, program-
med birth induction or elective Caesarean section just
before the term with verified intrauterine fetal maturity.
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FETALNA MAKROSOMIJA U TRUDNICA S GESTACIJSKIM DIJABETESOM
S A @ E T A K
Cilj rada je bio utvrditi u~estalost fetalne makrosomije u novoro|en~adi ro|enih od majki koje boluju od gestacijskog
dijabetesa melitusa (GDM) i zdravih majki, kao i utjecaj fetalnog rasta na na~in dovr{enja trudno}e i u~estalost kom-
plikacija u trudno}i, porodu i puerperiju, te neonatalnih komplikacija. U istra`ivanje je uklju~eno 351 trudnica s GDM i
1502 zdrave trudnice kao kontrolna skupina. Novoro|en~ad trudnica s GDM su zna~ajno ve}e porodne te`ine i duljine,
u~estalijeg PI>2,85, makrosomna su i hipertrofi~na (disproporcionalno i proporcionalno), imaju manje vrijednosti Ap-
gar indeksa i ve}u u~estalost neonatalnih komplikacija. (p<0,05). Fetalna makrosomija i fetalna hipertrofija same,
posebice udru`ene s disproporcionalnim fetalnim rastom, ali i disproporcionalna hipotrofija, imaju zna~ajan utjecaj na
pove}anu u~estalost komplikacija u porodu i puerperiju, dovr{enja poroda SC i neonatalnih komplikacija u trudnica s
GDM.
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